PARADIGM HEALTH SUBMITS RESPONSE TO FDA'S REAL-TIME CLINICAL TRIALS INITIATIVE RFI, INFORMED BY BIOPHARMA SPONSORS AND PROVIDERS

PARADIGM HEALTH SUBMITS RESPONSE TO FDA'S REAL-TIME CLINICAL TRIALS INITIATIVE RFI, INFORMED BY BIOPHARMA SPONSORS AND PROVIDERS

COLUMBUS, Ohio, June 30, 2026 /PRNewswire/ -- Paradigm Health, the sole technology provider operationalizing the U.S. Food and Drug Administration's (FDA) Real-Time Clinical Trials (RTCT) proof-of-concept studies, has formally submitted its response to the FDA's Request for Information (RFI) regarding…